Anti-BKRB2/ BDKRB2/ B2R monoclonal antibody

Anti-BKRB2/ BDKRB2/ B2R antibody for FACS & in-vivo assay

Target products collectionGo to BDKRB2/BDKRB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T23714-Ab-1/ GM-Tg-hg-T23714-Ab-2Anti-Human BDKRB2 monoclonal antibodyHuman
GM-Tg-rg-T23714-Ab-1/ GM-Tg-rg-T23714-Ab-2Anti-Rat BDKRB2 monoclonal antibodyRat
GM-Tg-mg-T23714-Ab-1/ GM-Tg-mg-T23714-Ab-2Anti-Mouse BDKRB2 monoclonal antibodyMouse
GM-Tg-cynog-T23714-Ab-1/ GM-Tg-cynog-T23714-Ab-2Anti-Cynomolgus/ Rhesus macaque BDKRB2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T23714-Ab-1/ GM-Tg-felg-T23714-Ab-2Anti-Feline BDKRB2 monoclonal antibodyFeline
GM-Tg-cang-T23714-Ab-1/ GM-Tg-cang-T23714-Ab-2Anti-Canine BDKRB2 monoclonal antibodyCanine
GM-Tg-bovg-T23714-Ab-1/ GM-Tg-bovg-T23714-Ab-2Anti-Bovine BDKRB2 monoclonal antibodyBovine
GM-Tg-equg-T23714-Ab-1/ GM-Tg-equg-T23714-Ab-2Anti-Equine BDKRB2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T23714-Ab-1/ GM-Tg-hg-T23714-Ab-2; GM-Tg-rg-T23714-Ab-1/ GM-Tg-rg-T23714-Ab-2;
GM-Tg-mg-T23714-Ab-1/ GM-Tg-mg-T23714-Ab-2; GM-Tg-cynog-T23714-Ab-1/ GM-Tg-cynog-T23714-Ab-2;
GM-Tg-felg-T23714-Ab-1/ GM-Tg-felg-T23714-Ab-2; GM-Tg-cang-T23714-Ab-1/ GM-Tg-cang-T23714-Ab-2;
GM-Tg-bovg-T23714-Ab-1/ GM-Tg-bovg-T23714-Ab-2; GM-Tg-equg-T23714-Ab-1/ GM-Tg-equg-T23714-Ab-2
Products NameAnti-BDKRB2 monoclonal antibody
Formatmab
Target NameBDKRB2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BDKRB2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species BKRB2/ BDKRB2/ B2R VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAD000226mouse Bdkrb2 Adenovirus plasmid
    ORF Viral VectorvGMAD000226mouse Bdkrb2 Adenovirus particle


    Target information

    Target IDGM-T23714
    Target NameBDKRB2
    Gene ID624,12062,25245,703698,538896,100054796
    Gene Symbol and SynonymsB(2),B2,B2BKR,B2BRA,B2R,BDKRB2,BK-2,BK2,BK2R,BKR2,BRB2
    Uniprot AccessionP30411,P25023
    Uniprot Entry NameBKRB2_HUMAN,BKRB2_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000168398
    Target ClassificationN/A

    The target: BDKRB2, gene name: BDKRB2, also named as B2R, BK-2, BK2, BKR2, BRB2. This gene encodes a receptor for bradykinin. The 9 aa bradykinin peptide elicits many responses including vasodilation, edema, smooth muscle spasm and pain fiber stimulation. Bradykinin is released upon activation by pathophysiologic conditions such as trauma and inflammation, and binds to its kinin receptors, B1 and B2. The B2 receptor associates with G proteins that stimulate a phosphatidylinositol-calcium second messenger system. [provided by RefSeq, Apr 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.